Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report

Zui Narita,1 Harumasa Takano,1 Tomiki Sumiyoshi2 1Department of Psychiatry, National Center Hospital, 2Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan Abstract: Neuromyelitis optica (NMO) is a relapsing disease that typic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Narita Z, Takano H, Sumiyoshi T
Format: article
Langue:EN
Publié: Dove Medical Press 2017
Sujets:
Accès en ligne:https://doaj.org/article/96bbde8a6da74501ad7b64be14c4c66f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
id oai:doaj.org-article:96bbde8a6da74501ad7b64be14c4c66f
record_format dspace
spelling oai:doaj.org-article:96bbde8a6da74501ad7b64be14c4c66f2021-12-02T02:55:28ZSuccessful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report1178-2021https://doaj.org/article/96bbde8a6da74501ad7b64be14c4c66f2017-03-01T00:00:00Zhttps://www.dovepress.com/successful-treatment-for-psychomotor-agitation-in-neuromyelitis-optica-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Zui Narita,1 Harumasa Takano,1 Tomiki Sumiyoshi2 1Department of Psychiatry, National Center Hospital, 2Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan Abstract: Neuromyelitis optica (NMO) is a relapsing disease that typically affects the spinal cord and optic nerves. So far, a few studies have reported pharmacologic treatment for psychiatric symptoms in patients with NMO spectrum disorder (NMOSD). However, no literature has described psychomotor agitation associated with the disease and its treatment. We report an 84-year-old woman with NMOSD whose psychomotor agitation was effectively treated with a combination of trazodone and risperidone. Our observation suggests the ability of augmentation of antipsychotic drugs with antidepressants to ameliorate psychotic symptoms associated with NMOSD. Keywords: neuromyelitis optica, multiple sclerosis, psychomotor agitation, trazodone, risperidoneNarita ZTakano HSumiyoshi TDove Medical PressarticleNeuromyelitis opticaMultiple sclerosisPsychomotor agitationTrazodoneRisperidoneNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 775-777 (2017)
institution DOAJ
collection DOAJ
language EN
topic Neuromyelitis optica
Multiple sclerosis
Psychomotor agitation
Trazodone
Risperidone
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neuromyelitis optica
Multiple sclerosis
Psychomotor agitation
Trazodone
Risperidone
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Narita Z
Takano H
Sumiyoshi T
Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report
description Zui Narita,1 Harumasa Takano,1 Tomiki Sumiyoshi2 1Department of Psychiatry, National Center Hospital, 2Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan Abstract: Neuromyelitis optica (NMO) is a relapsing disease that typically affects the spinal cord and optic nerves. So far, a few studies have reported pharmacologic treatment for psychiatric symptoms in patients with NMO spectrum disorder (NMOSD). However, no literature has described psychomotor agitation associated with the disease and its treatment. We report an 84-year-old woman with NMOSD whose psychomotor agitation was effectively treated with a combination of trazodone and risperidone. Our observation suggests the ability of augmentation of antipsychotic drugs with antidepressants to ameliorate psychotic symptoms associated with NMOSD. Keywords: neuromyelitis optica, multiple sclerosis, psychomotor agitation, trazodone, risperidone
format article
author Narita Z
Takano H
Sumiyoshi T
author_facet Narita Z
Takano H
Sumiyoshi T
author_sort Narita Z
title Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report
title_short Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report
title_full Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report
title_fullStr Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report
title_full_unstemmed Successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report
title_sort successful treatment for psychomotor agitation in neuromyelitis optica spectrum disorder with trazodone–risperidone combination: a case report
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/96bbde8a6da74501ad7b64be14c4c66f
work_keys_str_mv AT naritaz successfultreatmentforpsychomotoragitationinneuromyelitisopticaspectrumdisorderwithtrazodonendashrisperidonecombinationacasereport
AT takanoh successfultreatmentforpsychomotoragitationinneuromyelitisopticaspectrumdisorderwithtrazodonendashrisperidonecombinationacasereport
AT sumiyoshit successfultreatmentforpsychomotoragitationinneuromyelitisopticaspectrumdisorderwithtrazodonendashrisperidonecombinationacasereport
_version_ 1718402058613161984